who else can we blame? , page-12

Pigs- Yeah lack of liquidity is every species down fall, although you could argue that bios struggle more than others sectors- Aussie investors are too focused on resource stocks.

In terms of ACL- What are you suggesting is really going on behind the scenes? When you start putting all the pieces together it all seems a little suspicious to me……hopefully I’m just over analyzing the situation :)

I would agree with your general comments around BIO CEO’s, however I would argue that Pete has done well to have an FDA approval, while keeping ACL’s dilution down....so far.

Like you say- ACL started out to make carbohydrate drugs, which is probably something that long term/ top shareholders haven’t forgotten. Would you agree that this could also be another reason towards why they would be prepared to split this company up? Is this something the current SP has factored in??

I’m not one that can comment on the behind the scenes dealings/ objectives of this company- that’s seems to be more TDA/Tower territory……I’m just here to offer a different perspective.

I would like to see these records you speak of though. Start digging…..